GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 1751 - 1800 of 39437 in total
PDB ID UniProt ID Title Descriptor ▲
5U7O Q2N0S5 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-626529 in Complex with Human Antibodies PGT122 and 35O22 at 3.8 Angstrom Envelope glycoprotein gp160, 35O22 FAB HEAVY CHAIN, 35O22 FAB LIGHT CHAIN, PGT122 FAB HEAVY CHAIN, PGT122 FAB LIGHT CHAIN
5U7O 5U7O Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-626529 in Complex with Human Antibodies PGT122 and 35O22 at 3.8 Angstrom Envelope glycoprotein gp160, 35O22 FAB HEAVY CHAIN, 35O22 FAB LIGHT CHAIN, PGT122 FAB HEAVY CHAIN, PGT122 FAB LIGHT CHAIN
5U7M Q2N0S5 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies PGT122 and 35O22 at 3.8 Angstrom Envelope glycoprotein gp160, 35O22 HEAVY CHAIN, 35O22 LIGHT CHAIN, PGT122 HEAVY CHAIN, PGT122 LIGHT CHAIN
5U7M 5U7M Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies PGT122 and 35O22 at 3.8 Angstrom Envelope glycoprotein gp160, 35O22 HEAVY CHAIN, 35O22 LIGHT CHAIN, PGT122 HEAVY CHAIN, PGT122 LIGHT CHAIN
6CH7 Q2N0S7 XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain
6CH7 6CH7 XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain
6CH7 Q2N0S6 XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain
6MU6 Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MU6 6MU6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MUF B3UEZ6 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MUF 6MUF Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MUF B3UES2 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MTJ Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MTJ 6MTJ Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MTN Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MTN 6MTN Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MU8 Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MU8 6MU8 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MU7 Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MU7 6MU7 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MUG B3UEZ6 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MUG 6MUG Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MUG B3UES2 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
5VIY Q2N0S6 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY P01834 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY P01834 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY S6B291 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY S6B291 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY Q8TCD0 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY Q8TCD0 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
6VKN Q2N0S6 BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
6VKN 6VKN BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
6VN0 Q2N0S6 BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
6VN0 6VN0 BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
6OZC Q2N0S6 BG505 SOSIP.664 with 2G12 Fab2 Envelope glycoprotein gp160, Envelope glycoprotein gp41, 2G12 Fab light chain, 2G12 Fab Heavy chain
6OZC 6OZC BG505 SOSIP.664 with 2G12 Fab2 Envelope glycoprotein gp160, Envelope glycoprotein gp41, 2G12 Fab light chain, 2G12 Fab Heavy chain
6OPN B3UES2 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6OPN B3UEZ6 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6OPN P01730 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6DCQ A0A2H4K974 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ S6B291 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ 6DCQ Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ S6B291 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ 6DCQ Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ Q8TCD0 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ Q8TCD0 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6SNE 6SNE crystal structure of LN01 Fab in complex with an HIV-1 gp41 peptide Envelope glycoprotein gp160, LN01 light chain, LN01 heavy chain
6SNE Q74599 crystal structure of LN01 Fab in complex with an HIV-1 gp41 peptide Envelope glycoprotein gp160, LN01 light chain, LN01 heavy chain

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024